Effect of Leukotriene Antagonist on NF-kappa B and AP-1 Activities and Levels of Interleukin-4, Interleukin-5 and Interleukin-10 with Steroid-resistant or Steroid-dependent Asthma

YU Qin-feng,DONG Liang,ZHANG Qi,CHEN Ming

DOI: https://doi.org/10.3321/j.issn:1005-4529.2005.09.008

2005-01-01

Abstract:OBJECTIVE To observe the effect of leukotriene antagonist on nuclear factor-kappa B(NF-κB) and(activator) protein-1(AP-1) activities and the levels of interleukin-4(IL-4), interleukin-5(IL-5) and interleukin-10(IL-10) with steroid-resistant(SR) or steroid-dependent(SD)asthma.METHODS Fifteen patients with SR or SD asthma were selected based on their clinical responses to prednisone therapy.The peripheral blood mononuclear cells(PBMCs) were separated and incubated with phytohemagglutinin(PHA) in vitro for 24h in the absence of or for 12,18 and 24 h in the presence of montelukast,respectively.Supernatants were collected.Expressions of(IL-4,) IL-5 and IL-10 mRNA were determined by enzyme-linked immunoadsorbent assay(ELISA).The NF-κB and AP-1 activities of PBMCs were measured by electrophoretic mobility shift assay(EMSA).RESULTS In the(presence) of montelukast, the activities of NF-κB and AP-1 were significantly lower than those of incubation in media alone,meanwhile,the expressions of IL-4 and IL-5 were significantly lower and IL-10 were significantly higher,respectively(P0.05).CONCLUSIONS Montelukast could influence the activities of NF-κB and AP-1 and the(levels) of IL-4,IL-5 and IL-10, SR or SD asthma could be treated more effectively.